Curetis MDx System, Pneumonia Test Cleared in Russia, Serbia | GenomeWeb

NEW YORK (GenomeWeb News) — Curetis said today that its Unyvero system and its Unyvero P50 pneumonia assay have been registered and cleared by the Russian and Serbian Ministries of Health.

The first Unyvero system has already been installed at the Central Clinical Hospital of the Presidential Administration of the Russian Federation in Moscow and another will be tested at a major hospital in St. Petersburg, Curetis said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.